NCT06335446

Brief Summary

Atrial fibrillation (AF) is the most common sustained heart rhythm abnormality. Its incidence is increasing partly due to the aging population and it has been referred to as a growing epidemic. AF results in irregular contractions of the heart causing unpleasant symptoms of palpitations and increasing the risk of stroke, heart failure and death. Percutaneous catheter ablation is a safe treatment option in symptomatic patients with AF. The success rate of these procedures have improved with time due to our better understanding of AF, development of new techniques and technology, and greater physician experience. However, the success rate of these procedures still only remains around 70%. This is secondary to our limited ability to find the areas that drive AF. STAR mapping is a novel mapping system that has been developed with a view of better identifying the sites that drive AF through taking into account the mechanisms of AF we have so far demonstrated. To validate this mapping system we aim to use it in patients with atrial tachycardia (AT), which is a heart rhythm abnormality of which the mechanism can be readily identified with the existing mapping systems used in clinical practice. We will demonstrate that the STAR mapping algorithm can effectively map AT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
4.5 years until next milestone

First Posted

Study publicly available on registry

March 28, 2024

Completed
Last Updated

March 28, 2024

Status Verified

March 1, 2024

Enrollment Period

3 years

First QC Date

January 17, 2018

Last Update Submit

March 21, 2024

Conditions

Keywords

Atrial tachycardia, Electrogram, Ablation, Drivers

Outcome Measures

Primary Outcomes (1)

  • STAR maps compared to conventional maps

    The STAR maps demonstrating the source of the AT correlate with the maps created by the conventional mapping system.

    At procedure

Study Arms (1)

Atrial tachycardia- validation phase

The group will consist of patients with AT (whether de novo or occurring post AF ablation) that are undergoing catheter ablation.

Other: Novel mapping algorithm

Interventions

Signals will be collected during the catheter ablation. These signals STAR maps will be created post procedure and these will be compared to the conventional maps used during the atrial tachycardia ablation. This will be used to validate the STAR maps created.

Also known as: STAR MAPPING
Atrial tachycardia- validation phase

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with AT (whether de novo or occurring post AF ablation) undergoing catheter ablation.

You may qualify if:

  • Patients able to provide informed consent
  • Patients with AT (whether de novo or occurring post AF ablation)

You may not qualify if:

  • Unwillingness to sign consent
  • Age \<18 years old
  • Contraindications for catheter ablation procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barts Heart Centre

London, EC1A 7BE, United Kingdom

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2018

First Posted

March 28, 2024

Study Start

October 1, 2016

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

March 28, 2024

Record last verified: 2024-03

Locations